Видео ютуба по тегу Fcrh5

Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024
BCMA/GPRC5D/FcRH5 – CARs/BsAbs – Clinical Update | Ajai Chari, MD, PhD | IMS 2024
BCMA/GPRC5D/FcRH5 – CARs/BsAbs – Clinical Update | Ajai Chari, MD, PhD | IMS 2024
GPRC5D and FCRH5 Targeted Therapies in Myeloma
GPRC5D and FCRH5 Targeted Therapies in Myeloma
Bispecifics & CARs: BCMA, GPRC5D & FcRH5 sequencing
Bispecifics & CARs: BCMA, GPRC5D & FcRH5 sequencing
The importance of BCMA, FcRH5 and GPRC5D in multiple myeloma
The importance of BCMA, FcRH5 and GPRC5D in multiple myeloma
Going beyond BCMA-targeting agents in myeloma: GPRC5D and FcRH5-targeting therapies
Going beyond BCMA-targeting agents in myeloma: GPRC5D and FcRH5-targeting therapies
Beyond BCMA: GPRC5D & FcRH5
Beyond BCMA: GPRC5D & FcRH5
Phase I trial of a FcRH5-targeted BiTE in R/R myeloma
Phase I trial of a FcRH5-targeted BiTE in R/R myeloma